Serum sample |
GTI-Screening
Class I / II ELISA |
Luminex (SD)
Class I / Class II |
ELISA-Crossm.
Class I / Class II |
06/2010 & |
neg./neg. |
n.d./n.d. |
n.d./n.d. |
08/2010 $ |
neg./neg. |
neg./neg.
(PRA=0%) |
neg./neg. (AMS) |
07/2011 * |
neg./neg. |
n.d./n.d. |
n.d./n.d. |
08/2012 * |
neg./neg. |
neg./neg.
(PRA=0%) |
n.d./n.d. |
08/2013 * |
neg./neg. |
n.d./n.d. |
n.d./n.d. |
11/2014 * |
neg./neg. |
neg./neg.
(PRA=0%) |
n.d./n.d. |
03/2015 # |
neg./neg. |
neg./neg.
(PRA=0%) |
neg./neg. (AbCr.) |
for 03/2015 additionally:
LAT 1HD (anti-HLA class I Single Antigen ELISA): negative
LAT 1288 (anti-HLA class I/II Single Donor ELISA): negative |
n.d.: not done; neg.: negative; pos.: positive; PRA%: Panel Reactive Antibodies %; SD: Single Donor Resolution; &: analyses for entering the waiting list; $: analyses at the date of the transplantation; *: routinely performed post-trans-plantation analyses; #: analyses at the date of the clinically proven rejection episode; (AMS), (AbCr.): after its discontinuation in 2013 the AMS-crossmatch ELISA was replaced by the highly modified AbCross-crossmatch ELISA |